Effect of coinfusion of dexamethasone to oxaliplatin on hypersensitivity reactions induced by oxaliplatin in patients with colorectal cancer treated with XELOX

被引:0
|
作者
Aisu, Naoya [1 ]
Yoshida, Yoichiro [1 ]
Miyake, Toru [1 ]
Tanimura, Syu [1 ]
Hoshino, Seiichiro [1 ]
Yamashita, Yuichi [1 ]
机构
[1] Fukuoka Univ, Sch Med, Dept Surg Gastroenterol, Fukuoka 81401, Japan
关键词
D O I
10.1200/jco.2013.31.4_suppl.560
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
560
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Neurotoxicity of oxaliplatin in patients treated for colorectal cancer: FOLFOX versus XELOX
    Aliance, H.
    Gbomari-Bezza, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] OXALIPLATIN-INDUCED HYPERSENSITIVITY REACTIONS IN PATIENTS WITH ADVANCED COLORECTAL CANCER IN A SINGLE HOSPITAL
    Naganobu, N.
    Ureshino, N.
    Gondou, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 151 - 151
  • [3] Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction
    M Wasif Saif
    Shailja Roy
    Leslie Ledbetter
    Jennifer Madison
    Kostas Syrigos
    World Journal of Gastroenterology, 2007, (39) : 5277 - 5281
  • [4] Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction
    Saif, M. Wasif
    Roy, Shailja
    Ledbetter, Leslie
    Madison, Jennifer
    Syrigos, Kostas
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (39) : 5277 - 5281
  • [5] Successful Rechallenge for Oxaliplatin Hypersensitivity Reactions in Patients with Metastatic Colorectal Cancer
    Yanai, Takako
    Iwasa, Satoru
    Hashimoto, Hirhonobu
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    Yamamoto, Hiroshi
    ANTICANCER RESEARCH, 2012, 32 (12) : 5521 - 5526
  • [6] Clinical Analysis of Hypersensitivity Reactions to Oxaliplatin Among Colorectal Cancer Patients
    Shen, Yuping
    Li, Chunyan
    Liu, Weixing
    Mao, Wei
    Qian, Hong
    Wang, Hui
    Xu, Qing
    ONCOLOGY RESEARCH, 2018, 26 (05) : 801 - 807
  • [7] Risk Factors for Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer
    Seki, Kyoko
    Senzaki, Kenzou
    Tsuduki, Yasuo
    Ioroi, Takeshi
    Fujii, Michiko
    Yamauchi, Hiroko
    Shiraishi, Yukinari
    Nakata, Izumi
    Nishiguchi, Kohshi
    Matsubayashi, Teruhisa
    Takakubo, Yoshihide
    Okamura, Noboru
    Yamamori, Motohiro
    Tamura, Takao
    Sakaeda, Toshiyuki
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2011, 8 (03): : 210 - 215
  • [8] High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin
    Yasuhiro Kidera
    Taroh Satoh
    Shinya Ueda
    Wataru Okamoto
    Isamu Okamoto
    Soichi Fumita
    Kimio Yonesaka
    Hidetoshi Hayashi
    Chihiro Makimura
    Kunio Okamoto
    Hidemi Kiyota
    Junji Tsurutani
    Masaki Miyazaki
    Masahiro Yoshinaga
    Kimiko Fujiwara
    Yuzuru Yamazoe
    Kenzo Moriyama
    Masanobu Tsubaki
    Yasutaka Chiba
    Shozo Nishida
    Kazuhiko Nakagawa
    International Journal of Clinical Oncology, 2011, 16 : 244 - 249
  • [9] High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin
    Kidera, Yasuhiro
    Satoh, Taroh
    Ueda, Shinya
    Okamoto, Wataru
    Okamoto, Isamu
    Fumita, Soichi
    Yonesaka, Kimio
    Hayashi, Hidetoshi
    Makimura, Chihiro
    Okamoto, Kunio
    Kiyota, Hidemi
    Tsurutani, Junji
    Miyazaki, Masaki
    Yoshinaga, Masahiro
    Fujiwara, Kimiko
    Yamazoe, Yuzuru
    Moriyama, Kenzo
    Tsubaki, Masanobu
    Chiba, Yasutaka
    Nishida, Shozo
    Nakagawa, Kazuhiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (03) : 244 - 249
  • [10] Clinical characteristics and risk factors for oxaliplatin hypersensitivity reactions in patients with colorectal cancer
    Kim, Jeong Hye
    Jung, Mi Kyoung
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025, 31 (01) : 17 - 21